HIGHLIGHTS
- who: Shiri Meron-Sudai and colleagues from the School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel have published the article: Pentraxin 3 and Shigella LPS and IpaB Antibodies Interplay to Defeat Shigellosis, in the Journal: (JOURNAL) of 28/07/2022
- what: The authors quantified the presence of PTX3 in serum and stool samples of cases of culture proven shigellosis and studied the interplay between levels of PTX3 as a component of the innate immune_response and the levels of anti-Shigella lipopolysaccharide (LPS) and anti-Shigella type 3 secretion system . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.